Prospective Validation Group:None

4 trials

Sponsors

Eastern Hepatobiliary Surgery Hospital, Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University), The First Affiliated Hospital of the Army Medical University of the People's Liberation Army of China, Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine

Conditions

Acute Kidney InjuryHepatocellular carcinoma (HCC)Liver cancerhepatocellular carcinoma

Unknown Phase

Construction and internal, external, and prospective validation study of a prediction model for extremely early recurrence after HCC resection (VERM-pre)

Active, not recruitingChiCTR2300077747

Eastern Hepatobiliary Surgery Hospitalhepatocellular carcinoma

Start: 2021-12-01Updated: 2023-11-21

A series of studies on the combined treatment of liver cancer using targeted and immunotherapy in the real world and transcatheter arterial chemoembolization

RecruitingChiCTR2600118057

Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)Liver cancer

Start: 2024-03-01Updated: 2026-02-09

Development and Validation of an Intelligent Predictive Model for Supportive Care Needs in Patients with Hepatocellular Carcinoma: A Multicenter Study

Active, not recruitingChiCTR2600125542

The First Affiliated Hospital of the Army Medical University of the People's Liberation Army of ChinaHepatocellular carcinoma (HCC)

Start: 2026-05-28Updated: 2026-06-01

Research on Artificial Intelligence-Based Decision Support System for Continuous Renal Replacement Therapy Liberation in Critically Ill Patients with Acute Kidney Injury

Active, not recruitingChiCTR2600126110

Renji Hospital affiliated to Shanghai Jiaotong University School of MedicineAcute Kidney Injury

Start: 2026-06-03Updated: 2026-06-08